Amir Manbachi
Johns Hopkins University, MD·Biomedical Engineering
Hospitalized patients can develop dangerous changes in blood flow, such as deep vein thrombosis (a blood clot in a deep vein), between routine check-ups. Current monitoring often depends on occasional ultrasound exams performed by specialized staff, so problems that arise between exams can be missed.
- Fields
Biomedical Engineering
Medicine & Clinical Research
Engineering
- Topics
wearable ultrasound
ultrasound patch
deep vein thrombosis
- Grants
- 1 known grant, through Jul 2027
What they work on
- Assess, through customer discovery interviews, the clinical need for continuous ultrasound monitoring of blood vessels in hospitalized patients at risk of deep vein thrombosis.
- Determine how a wearable ultrasound patch would fit into the workflows of critical care, surgical recovery and vascular health settings, and what barriers could slow its adoption.
- Evaluate reimbursement considerations and commercialization pathways for a device that combines a deep-imaging ultrasound transducer with AI-assisted electronic beam steering for automated vessel tracking.
More about the research
Late recognition leads to preventable complications, longer hospital stays and higher costs. This project centers on a wearable ultrasound patch designed to watch blood vessels continuously and flag meaningful changes automatically.
Why it matters
A wearable patch that continuously tracks blood vessels could help clinicians spot deep vein thrombosis and other vascular changes earlier in hospitalized, critically ill and post-surgical patients. That could add to existing clot-prevention strategies, reduce preventable deaths and complications, ease the demand on ultrasound specialists, lower costs, and widen access to DVT monitoring.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Julie Jaffray
University of California-San Diego, CA·Medicine & Clinical Research·Early-career
Prospectively validate a pediatric hospital-acquired venous thromboembolism (VTE) risk assessment model from the CHAT Consortium, using a case-control design and electronic medical record review.
Congqing Wu
University of Kentucky, KY·Medicine & Clinical Research
Determine how NINJ1 in myeloid immune cells such as macrophages contributes to thrombosis. NINJ1 is the protein that actively ruptures the cell membrane during pyroptosis, an inflammatory form of cell death.
Charles Lowenstein
Johns Hopkins University, MD·Medicine & Clinical Research
Test whether BCOR, a gene-silencing protein, suppresses Factor VII production in liver cells by controlling the epigenetic complexes PRC1.1 and ATAC, which regulate how DNA is packaged and read.
The school
Johns Hopkins University: 100 labs on PI Pages, $4.1B a year on research, 622 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.